Skip to main content
Alexander Turchin, MD, Endocrinology, Boston, MA

AlexanderTurchinMDMS, FACMI

Endocrinology Boston, MA

Diabetes, Lipid Metabolism

Associate Professor of Medicine, Harvard Medical School

Dr. Turchin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Turchin's full profile

Already have an account?

  • Office

    221 Longwood Avenue
    Rfb 2
    Boston, MA 02115
    Phone+1 617-732-5661

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2005
  • Tufts Medical Center
    Tufts Medical CenterResidency, Internal Medicine, 1999 - 2002
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Fellow American College of Medical Informatics, 2014
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Ambulatory Medication Reconciliation and Frequency of Hospitalizations and Emergency Department Visits in Patients with Diabetes  
    Alexander Turchin, MD, Diabetes Care

Lectures

  • Can Big Data and Novel Informatics Guide Cholesterol Care? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

  • Large Study Finds High Rates of Nonadherence to Statin Recommendations; Women Especially Averse
    Large Study Finds High Rates of Nonadherence to Statin Recommendations; Women Especially AverseMarch 3rd, 2023
  • A Fifth of the Patients in the Study Refused Statins, Despite Their Benefits
    A Fifth of the Patients in the Study Refused Statins, Despite Their BenefitsMarch 2nd, 2023
  • A Fifth of Patients in Study Refused Cholesterol-Lowering Drugs, Despite Benefits
    A Fifth of Patients in Study Refused Cholesterol-Lowering Drugs, Despite BenefitsFebruary 28th, 2023
  • Join now to see all